Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism
Objective: (1) To evaluate the differences in gut microbiota among Parkinson’s disease (PD), atypical parkinsonism (i.e. multiple system atrophy [MSA] and progressive supranuclear palsy [PSP])…STN DBS – A study of frequency of gait (fog) in Parkinson’s disease
Objective: In search of new techniques to help improve lifestyle of Parkinson`s diseased conditions (PDs), a wireless technique is proposed to identify freeze, reduce freeze,…Automated immunohistochemical detection of pathological alpha-synuclein in human tissue biopsy
Objective: The goals of this study were to create a highly sensitive brightfield immunohistochemical (IHC) assay for pathological alpha-synuclein (aSyn) in formalin-fixed, paraffin embedded (FFPE)…Categorising visual hallucinations in early Parkinson’s disease
Objective: To categorise visual hallucinations (VHs) in a cohort of newly diagnosed Parkinson’s disease (PD) patients and determine associations with clinical characteristics. Background: Visual hallucinations…Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy
Objective: We aimed to explore associated neural substrates changes in Parkinson’s disease (PD) with apathy via amplitude of low-frequency fluctuations (ALFF) and Granger Causality Analysis…Applying Intervention Mapping methodologies to enhance Data Completeness in Movement Disorders-related Scales
Objective: Describe the methodological steps and benchmarks needed to utilize Intervention Mapping as a strategy to enhance Data Completeness in Rating Scales relying on input…Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report
Objective: To explore the psychometric properties of the PD-PSS. Background: Evaluating pain in PD patients can be a difficult issue in the everyday clinical practice.…Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease
Objective: To determine if droxidopa improves gait speed, kyphosis, and functional reach in Parkinson’s disease when added to routine care treatment. Background: Fall risk factors…Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach
Objective: To evaluate the safety and efficacy of incobotulinumtoxinA (IncoA) injection for treatment of Essential Tremor (ET). Background: In essential tremor and Parkinson's Disease tremor,…Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia
Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 177
- Next Page »